Bispecific #Antibodies are lab-made proteins that can attach to two different targets at the same time to help the immune system fight diseases like cancer.
@knowledgezone.bsky.social
@knowledgezone.bsky.socialBispecific #Antibodies are lab-made proteins that can attach to two different targets at the same time to help the immune system fight diseases like cancer.
@knowledgezone.bsky.socialThe #Ross-Littlewood #Paradox: Is the #Vase Full Or Empty? : Medium
#Cancer-fighting #Antibodies with a one-two punch take aim at #Tumours ($) : Nature
Why the #Legendary #Erdos 3Problems Are Falling to #AI : Quanta Mag
Latest #KnowledgeLinks
@stephanhacker2.bsky.socialCongratulations to Angad Mehta on being one of the 2026 ICBS Young Chemical Biologist Awardees.
He gave a great award lecture: "In vitro immune-like systems for continuous directed evolution of biologics"
@antibodytx.bsky.socialAntibody Therapeutics (IF=4.8, Oxford University Press) ⚡ Review Highlight -Fundamental properties and principal areas of focus in antibody–drug conjugates formulation development.
doi.org/10.1093/abt/...
#mab #antibody #antibodies #adcs #formulation #formulationdevelopment
@proteintech.bsky.socialYour next Western blot could cost you less. 🧪
UK & European labs can save up to £780 on primaries, loading controls and HRP secondaries with Spend More, Save More.
Use code EUSPENDSAVE at checkout.
@howweknow.bsky.socialYour body's antibody factories.
Prof. Rafi Ahmed explains how some plasma cells survive in bone marrow niches and keep producing antibodies.
Full Burstcast: youtu.be/HAZkKVRiqVg
@mdpipharma.bsky.socialCould combining anti-CD38 #antibodies improve MM treatment? This study shows #isatuximab & daratumumab bind non-competitively, with distinct apoptosis profiles. Pomalidomide enhances isatuximab-induced cell death!
👉 www.mdpi.com/1999-4923/17...
#MultipleMyeloma #CD38 #TargetedTherapy #Immunotherapy
@plosbiology.orgPoorly validated #antibodies generate misleading results and waste research resources. @johanduchene.bsky.social explores two new @PLOSBiology.org studies quantifying these costs and identifying solutions.
🧪
Article 1 plos.io/3Ui0czP
Article 2 plos.io/4s1Ccxl
Primer plos.io/4hQh7kI
@plosbiology.orgPoorly validated #antibodies generate misleading results and waste research resources. @johanduchene.bsky.social explores two new @PLOSBiology.org studies quantifying these costs and identifying solutions.
🧪
Article 1 plos.io/3Ui0czP
Article 2 plos.io/4s1Ccxl
Primer plos.io/4hQh7kI
@newsramp.comCreative Biolabs launches a three-part antibody engineering framework targeting immunogenicity, efficacy, and manufacturability to help researchers accelerate preclinical development pipelines with greater confidence. #Antibodies #Biopharmaceuticals
@plosbiology.orgPoorly validated #antibodies misdirect research, wasting an estimated billion dollars and millions of biological samples each year. In this multi-stakeholder Delphi consensus study, experts agree on priority practical fixes, and who should deliver them, by 2030.
🧪 #AcademicSky
plos.io/3Ui0czP
@plosbiology.orgPoorly validated #antibodies generate misleading results and waste research resources. @johanduchene.bsky.social explores two new @PLOSBiology.org studies quantifying these costs and identifying solutions.
🧪
Article 1 plos.io/3Ui0czP
Article 2 plos.io/4s1Ccxl
Primer plos.io/4hQh7kI
@plosbiology.orgPoorly validated #antibodies misdirect research, wasting an estimated billion dollars and millions of biological samples each year. In this multi-stakeholder Delphi consensus study, experts agree on priority practical fixes, and who should deliver them, by 2030.
🧪 #AcademicSky
plos.io/3Ui0czP
@narrowit.bsky.socialDanaher Plans AI-Powered Lab to Speed Antibody Tool Development Danaher plans an autonomous laboratory linking AI, robotics and equipment from...
https://www.narrowit.com/news/danaher-plans-ai-powered-autonomous-lab-2026-10-07
#Danaher #ArtificialIntelligence #LaboratoryAutomation #Antibodies
@hellobio.bsky.socialChoosing the right antibody can make a big difference to the reliability of your results, and in this new article we share 6 key things to look for in antibody validation evidence 🙌
Read here: https://ow.ly/Eszq50ZVige
#antibody #antibodies #reproducibility #lifescience #validation #lifescience
@vaccinologist.bsky.socialResearchers at the University of South Florida @usf.edu identified a vulnerable site that #antibodies can target to block liver-cell invasion - preventing #infection before hypnozoites are established. Important advance vs. one of #malaria’s most difficult parasites. lnkd.in/p/exmyCQ8G
@retropz.bsky.socialNew #ResearchIntegrity blog from @cancerresearchuk.org on validation of #antibodies:
"If as a focused cancer research community we can embed antibody validation practices, we can protect the integrity of our research"
Rebecca Harris, Therapeutic Innovation team, @crhorizons.bsky.social
@diseaseatlas.bsky.socialHalf the modality question is answered by where the target sits: inside the cell, small molecule; secreted, antibody. Disease Atlas by Euretos scores it from the biology. IL-13 is a secreted cytokine: small molecule not tractable, antibody reads high, two approved. #Antibodies
@akulmehta.bsky.socialIn this study we saw something unexpected. Normally antibodies against blood groups are stable for people, but in some people with SARS-CoV-2 infections we saw changes in their antibody profiles. Please check out our latest work.
#COVID19 #Immunology #BloodGroups #Antibodies #Glycobiology #Glycotime
@thencfg.bsky.socialOur new study reveals SARS-CoV-2 infection causes unpredictable fluctuations in anti-ABO(H) blood group antibodies.
Read the paper at: pubs.acs.org/acbcct/artic...
#COVID19 #Immunology #BloodGroups #Antibodies #Glycobiology #Transplantation #Glycotime